Chiba, Japan

Yuko Ikeda


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Chiba, JP (1994 - 1996)
  • Matsudo, JP (1998)
  • Matsudo-shi, Chiba-ken, JP (1998)

Company Filing History:


Years Active: 1994-1998

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Yuko Ikeda: Innovator in Pharmaceutical Composition

Introduction

Yuko Ikeda is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of aromatase-inhibiting compositions. With a total of 11 patents to her name, her work has had a considerable impact on medical science.

Latest Patents

Her latest patents include an aromatase-inhibiting composition containing an azole derivative. This pharmaceutical composition comprises an effective amount of a compound selected from a specific group of compounds, including their stereoisomers and salts. The detailed formula includes various components, such as halogen or phenyl groups, and specific alkyl configurations, which contribute to its effectiveness as a treatment.

Career Highlights

Throughout her career, Yuko Ikeda has worked with notable companies, including Kureha Chemical Industry Company, Limited and Kureha Kagaku Kogyo Kabushiki Kaisha. Her experience in these organizations has allowed her to refine her skills and contribute to innovative pharmaceutical solutions.

Collaborations

Yuko has collaborated with esteemed colleagues, including Koichi Niimura and Takao Ando. These partnerships have fostered a creative environment that has led to groundbreaking advancements in her field.

Conclusion

Yuko Ikeda's contributions to pharmaceutical innovation are noteworthy, and her patents reflect her dedication to advancing medical science. Her work continues to influence the development of effective treatments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…